National

About 18,500 Koreans get COVID-19 vaccines on vaccination Day 1

Feb 27, 2021

Seoul (South Korea), February 27: About 18,500 people received a vaccination for COVID-19 in South Korea on the launch day of the nation's public vaccination campaign against the pandemic, a government agency said Saturday.
According to the Central Disaster and Safety Countermeasure Headquarters, 18,489 people across the country got their first shots of the two-dose AstraZeneca vaccine Friday.
"On Friday, 18,489 medical workers, health care workers and nursing home patients received the AstraZeneca vaccine at community health centers and 213 nursing facilities in 17 metropolitan cities and provinces as planned," said Jeon Hae-cheol, minister of the Interior and Safety, in an agency meeting.
The minister noted there have been no reports of specific adverse reactions from vaccine recipients, except for mild symptoms, such as headaches and fever.
The first day tally of vaccinations represents 6.39 percent of 289,480 health care workers and patients under 65 years of age who had agreed to the vaccination. It also accounts for 0.04 percent of the nation's population of 52 million.
By region, Gyeonggi Province, which surrounds Seoul, accounted for 3,532 of the Day 1 vaccine recipients, followed by 3,072 in Gwangju and 1,922 in the capital.
The administering of Pfizer's vaccine also began at the National Medical Center in Seoul on Saturday. The first shipment of 58,500 doses of Pfizer's vaccine arrived in Korea on Friday and an additional 500,000 doses are due to arrive at the beginning of the third week of March.
About 300 medical and other workers -- 199 from the National Medical Center and 101 from other hospitals specializing in the treatment of COVID-19 patients -- are to receive the Pfizer vaccine.
The nation's first recipient of the Pfizer vaccine was a 51-year-old sanitation worker of the National Medical Center, named Chung Mi-kyeong, who got the shot at 9:04 a.m., according to government officials.
Source: Yonhap

More news

XLRI and Dale Carnegie India Partner to Embed World-Class Behavioural Skills into Indian Management Education

Mumbai (Maharashtra) [India], July 13: Two institutions, bound by a single conviction -- that careers are built on people, not paper -- have decided to build together. XLRI Leadership Education and Development (XLEAD), the executive education arm of XLRI - Xavier School of Management, and Dale Carnegie India today announced a strategic partnership to weave world-class behavioural and people-skills training into the fabric of Indian management education, jointly designing and delivering leadership and behavioural development programmes for the country's professionals and executives.Formalised through a Memorandum of Understanding, the long-term partnership brings together two complementary strengths: XLRI's standing as one of India's foremost management institutions, and Dale Carnegie India's globally proven expertise in behavioural and people-skills development. The two will jointly design and deliver programmes that build the human capabilities professionals increasingly need to lead and grow, and will be integrated across domains with industry-read certifications.

Jul 13, 2026